Williams I P, McGavin C R
Br J Dis Chest. 1980 Apr;74(2):142-8. doi: 10.1016/0007-0971(80)90025-x.
In a study to examine the methods of assessing the response of patients with chronic airways obstruction to corticosteroids, 20 patients received a week of placebo tablets, followed by three weeks of prednisolone 30 mg daily. Subjective benefit was assessed by a visual analogue scale (VAS), and objective changes by spirometry and an exercise test. Significant increases in FEV1 and in exercise performance were observed after steroid therapy. Changes in FVC correlated both with VAS score and with changes in exercise performance. Changes in FEV1 correlated with neither. The good correlation between the changes in a ventilatory function test (the FVC) and the patients' assessments of the drug suggests that the non-specific euphoriant effect of steroids does not eclipse their specific action on ventilatory function. Assessment of benefit should include a subjective assessment and changes in FVC and exercise performance. Changes in FEV1 appear to have less clinical relevance.
在一项旨在研究评估慢性气道阻塞患者对皮质类固醇反应方法的研究中,20名患者先服用一周安慰剂片,随后每日服用30毫克泼尼松龙,持续三周。主观疗效通过视觉模拟量表(VAS)评估,客观变化通过肺活量测定法和运动试验评估。类固醇治疗后观察到第一秒用力呼气容积(FEV1)和运动能力显著增加。用力肺活量(FVC)的变化与VAS评分以及运动能力的变化均相关。FEV1的变化与两者均无关联。通气功能测试(FVC)的变化与患者对药物的评估之间的良好相关性表明,类固醇的非特异性欣快作用并未掩盖其对通气功能的特定作用。疗效评估应包括主观评估以及FVC和运动能力的变化。FEV1的变化似乎临床相关性较小。